美国全国HIV分子簇检测的CDC与州及地方卫生部门实施
本文介绍美国CDC自2016年起以27个辖区数据启动HIV分子簇检测,2016—2023年扩展至全国序列报告并部署Secure HIV-TRACE应用;CDC每季度检测、州及地方卫生部门每月分析本地数据,2020年起辖区常规上报簇。2018—2023年CDC识别404个快速传播分子簇,其中325个(80%)涉及多个辖区;2020—2023年辖区上报298个簇,249个由辖区首先发现。
要点
- CDC每季度开展分子簇检测,州及地方卫生部门每月分析本地数据。
- 2018—2023年CDC识别404个快速HIV传播分子簇,325个(80%)涉及多辖区。
- 2020—2023年辖区上报298个分子簇,其中249个由辖区首先发现。
核心结论
- 扩展分子簇检测为改善对经历快速HIV传播网络的服务提供奠定了基础。
研究设计与样本
- CDC于2016年以27个辖区数据启动分子簇检测,2016—2023年扩展全国序列报告并部署Secure HIV-TRACE应用。
- CDC每季度开展分子簇检测;州及地方卫生部门每月分析本地数据;辖区自2020年起使用簇报告表常规上报CDC。
主要发现
- 2018—2023年CDC识别404个快速HIV传播分子簇。
- 404个簇中325个(80%)涉及多个辖区。
- 2020—2023年辖区向CDC报告298个分子簇,其中249个由辖区首先发现。
临床怎么用
- CDC每季度开展分子簇检测,州及地方卫生部门每月分析本地数据并自2020年起常规上报簇。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Detecting and responding to clusters of rapid HIV transmission is a core HIV prevention strategy in the United States, guiding public health interventions and identifying gaps in prevention and care services. In 2016, the Centers for Disease Control and Prevention (CDC) initiated molecular cluster detection using data from 27 jurisdictions. During 2016-2023, CDC expanded sequence reporting nationwide and deployed Secure HIV-TRACE, an application supporting health department (HD) molecular cluster detection. CDC conducts molecular cluster detection quarterly; state and local HDs analyze local data monthly. HDs began routinely reporting clusters to CDC by using cluster report forms in 2020. During 2018-2023, CDC identified 404 molecular clusters of rapid HIV transmission; 325 (80%) involved multiple jurisdictions. During 2020-2023, HDs reported 298 molecular clusters to CDC; 249 were first detected by HDs. Expanding molecular cluster detection has provided a foundation for improving service delivery to networks experiencing rapid HIV transmission.
引用
- France AM, Hallmark CJ, Panneer N, et al. Nationwide Implementation of HIV Molecular Cluster Detection by Centers for Disease Control and Prevention and State and Local Health Departments, United States. Emerg Infect Dis. 2025. PMID: 40359087. doi:10.3201/eid3113.241143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。